Abstract 593: Bispecific antibody against TIGIT and PVRIG enhances antitumor immunity
Sign Up to like & getrecommendations! Published in 2023 at "Cancer Research"
DOI: 10.1158/1538-7445.am2023-593
Abstract: T cell immunoreceptor with Ig and ITIM domains (TIGIT) and poliovirus receptor-related immunoglobulin domain-containing protein (PVRIG) are two immune checkpoint receptors. They compete with CD226 for binding to CD155 or CD112 and suppress the activity… read more here.
Keywords: antibody tigit; bispecific antibody; pvrig enhances; tigit pvrig ... See more keywords